I suffered a career-ending injury in the past and now have further health issues related to that incident. How do you keep from going into a deep depression when you lost your job, have undergone 12 surgical procedures and almost three years of rehab since 2002? I have battled depression, lack of self-worth and confidence.
Chances are, someone you know takes a sleeping pill. One in four Americans takes a sleep aid every year, according to the National Sleep Foundation, and the numbers are even higher for women -- one in three uses some sort of sleep medication a few times a week.
Ever since Paul Lewis was a kid, he was a restless sleeper who sleepwalked now and then. But after he started his company, a forensic investigations firm called PG Lewis and Associates in Whitehouse Station, N.J., he found he never slept soundly enough to sleepwalk.
Drug makers spend billions on slick direct-to-consumer ads. The biggest weapon in their marketing arsenal? Confusion
CNN's Elizabeth Cohen reports on a new study linking loud snoring with an increased risk of cardiovascular disease.
Insomnia sufferers have a lot to keep them awake at night: many of the available drugs are loaded with side-effects, and big drugmakers can't seem to get their act together on new treatments.
Shares of Sepracor were up 5 percent this morning after the Marlborough-based drug maker reached a marketing agreement for its insomnia treatment, Lunesta.
Sepracor Inc .posted lower-than-expected results Friday and cut its 2007 outlook amid competition for its insomnia drug and reduced reimbursement for its asthma drug, sending its shares down 20 percent.
Business 2.0: Hits & Missesupdated: Mon Apr 23 2007 18:02:00
[MISS] Leave out the beaver. Memorable ads lead to memorable results, right? Not always. After unveiling a well-received campaign featuring Abe Lincoln and a bucktoothed rodent, Japanese drugmaker ...
Eli Lilly & Co. agreed to buy Hypnion, a privately owned company specializing in treatments for sleep disorders, the companies said Monday.
Your alarm jolts you into consciousness every weekday morning; you need a cup or two of joe just to get out the door--and two or three more to make it through the day. You rub your eyes to stay awa...
Pfizer and Schering-Plough could easily snap up the smaller drugmaker Sepracor but industry analysts say risks to its two products would limit any potential gains.
Pfizer could use a new blockbuster and the sleeping pill industry could use a new drug, and both could happen this summer if the FDA approves Indiplon at its review later this month.
The fast-growing sleeping-pill business could be in for a big wake-up call from Pfizer.
Oh, the agony of sleeplessness. "Last night she had only slept three hours with five red ones and two yellows," mourns Neely, a character in Valley of the Dolls, Jacqueline Susann's great work of p...
Your bodyclock is in one time zone and you're physically in another, at some point during a business trip, you are going to need some help.
A new pill from Japanese drug maker Takeda Pharmaceuticals promises to put you to sleep without knocking you out.
© 2013 Cable News Network. Turner Broadcasting System, Inc. All Rights Reserved.
|